CR Sanjiu Medical to Buy 28% Stake in Tasly Pharma for Over 6 Billion Yuan; Tasly Shares Down 4%

MT Newswires Live2024-08-06

China Resources Sanjiu Medical and Pharmaceutical (SHE:000999) plans to acquire a 28% stake in its local peer Tasly Pharmaceutical (SHA:600535) for 6.21 billion yuan, according to a Sunday filing on the Shenzhen Stock Exchange.

CR Sanjiu will buy the stake from Tasly Great Health Industry Investment Group or Tasly Group and six other investors, which are all limited partnerships.

Tasly Group also committed to transferring 5% of Tasly's shares to CR Sanjiu's shareholder, Guoxin Investment, after the registration date, the filing noted.

Tasly's shares dropped more than 4% in recent trade in Shanghai, while CR Sanjiu's shares were marginally down in Shenzhen.

Price (RMB): Â¥42.17, Change: Â¥-0.17, Percent Change: -0.40%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2457068648?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-06 12:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2457068648","market":"sg","top_or_hot":-1,"title":"CR Sanjiu Medical to Buy 28% Stake in Tasly Pharma for Over 6 Billion Yuan; Tasly Shares Down 4%","media":"MT Newswires Live","content":"<html><body><p> China Resources Sanjiu Medical and Pharmaceutical (SHE:000999) plans to acquire a 28% stake in its local peer Tasly Pharmaceutical (SHA:600535) for 6.21 billion yuan, according to a Sunday filing on the Shenzhen Stock Exchange.</p><p>CR Sanjiu will buy the stake from Tasly Great Health Industry Investment Group or Tasly Group and six other investors, which are all limited partnerships.</p><p>Tasly Group also committed to transferring 5% of Tasly's shares to CR Sanjiu's shareholder, Guoxin Investment, after the registration date, the filing noted.</p><p>Tasly's shares dropped more than 4% in recent trade in Shanghai, while CR Sanjiu's shares were marginally down in Shenzhen.</p><p>Price (RMB): Â¥42.17, Change: Â¥-0.17, Percent Change: -0.40%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Sanjiu Medical to Buy 28% Stake in Tasly Pharma for Over 6 Billion Yuan; Tasly Shares Down 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Sanjiu Medical to Buy 28% Stake in Tasly Pharma for Over 6 Billion Yuan; Tasly Shares Down 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-06 12:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China Resources Sanjiu Medical and Pharmaceutical (SHE:000999) plans to acquire a 28% stake in its local peer Tasly Pharmaceutical (SHA:600535) for 6.21 billion yuan, according to a Sunday filing on ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0185","symbol_name":"二线龙头","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2457068648","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2457068648","pubTimestamp":1722919671,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Sanjiu Medical and Pharmaceutical  plans to acquire a 28% stake in its local peer Tasly Pharmaceutical  for 6.21 billion yuan, according to a Sunday filing on the Shenzhen Stock Exchange.CR Sanjiu will buy the stake from Tasly Great Health Industry Investment Group or Tasly Group and six other investors, which are all limited partnerships.Tasly Group also committed to transferring 5% of Tasly's shares to CR Sanjiu's shareholder, Guoxin Investment, after the registration date, the filing noted.Tasly's shares dropped more than 4% in recent trade in Shanghai, while CR Sanjiu's shares were marginally down in Shenzhen.Price : 42.17, Change: -0.17, Percent Change: -0.40%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600535":"天士力","BK0185":"二线龙头","BK0196":"行业龙头","BK0239":"医药制造","CR":"crane","000999":"华润三九","BK0183":"MSCI概念","BK0010":"央企","BK0175":"白马股","BK0012":"证金概念","BK0188":"融资融券","BK0028":"国家队","BK0060":"抗癌","BK4161":"工业机械"},"translate_title":"华润三九医疗拟超60亿元收购天士力医药28%股权；天士力股价下跌4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600535":0.9,"CR":1,"000999":0.9},"content_text":"China Resources Sanjiu Medical and Pharmaceutical (SHE:000999) plans to acquire a 28% stake in its local peer Tasly Pharmaceutical (SHA:600535) for 6.21 billion yuan, according to a Sunday filing on the Shenzhen Stock Exchange.CR Sanjiu will buy the stake from Tasly Great Health Industry Investment Group or Tasly Group and six other investors, which are all limited partnerships.Tasly Group also committed to transferring 5% of Tasly's shares to CR Sanjiu's shareholder, Guoxin Investment, after the registration date, the filing noted.Tasly's shares dropped more than 4% in recent trade in Shanghai, while CR Sanjiu's shares were marginally down in Shenzhen.Price (RMB): Â¥42.17, Change: Â¥-0.17, Percent Change: -0.40%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2457068648"}